No Result
View All Result
Thursday, June 11, 2026
Patriot TV Defenders Members
Patriot TV
  • Home
    • About
  • Posts
  • Home
    • About
  • Posts
No Result
View All Result
PatriotTV
No Result
View All Result
Home Articles Curated
Adolescents with Heart Damage After Covid ‘Vaccine’ Face Long-Term Health Challenges, Study Warns

How Long Has Industry Captured Vaccine Regulation?

by Jeffrey A. Tucker
December 25, 2025

(Infowars)—Among the many incredible revelations over the past five years is the extent of the power of the pharmaceutical companies. Through advertising, they have been able to shape media content. That in turn has affected digital content companies, which responded from 2020 onward by taking down posts that questioned the safety and efficacy of Covid vaccines.

They have captured universities and medical journals with donations and other forms of financial control. Finally, they are far more decisive in driving the agenda of governments than we ever knew. Just for example, we found out in 2023 that the NIH shared thousands of patents with pharma, with a market value approaching $1-2 billion. This was all made possible by the Bayh-Dole Act of 1980, which was pushed as a form of privatization but only ended up entrenching the worst corporatist corruptions.

The hold over governments was cemented with the National Childhood Vaccine Injury Act of 1986, which granted a liability shield to the makers of products that appear on the childhood schedule. The injured are simply not permitted to fight it out in civilian courts. No other industry enjoys such sweeping indemnification under the law.

Pharma today arguably competes with the military munitions industry in its hold over power. No other industry in human history has managed to close the economies of 194 countries to force most of the world’s population to wait for its inoculation. Such power makes the East India Company, against which the American founders revolted, look like a corner grocery by comparison.

There is ample talk about how much pharma has suffered since its vaunted product flopped. But let’s not be naive. Their power is still ubiquitously on display in every sector of society. The fight at the state level for over-the-counter therapeutics – and for medical freedom for the citizenry – reveals the scope of the challenges ahead. The reformers that now head agencies in Washington are fighting daily through a thicket of influence that goes back many decades.

Just how far in the past does this power extend? The first federal effort to push vaccination – however primitive and dangerous – was from President James Madison. “The Act to Encourage Vaccination” of 1813 required that smallpox vaccines be given away for free and properly delivered to anyone who requests them. As injury and death piled up, and amidst cries of profiteering and corruption, Congress acted decisively in 1822 to repeal the act.

The turning point in public opinion was what came to be known as the Tarboro Tragedy. The most reputed vaccinologist in the country and the official guardian of the vaccine, Dr. James Smith, had accidentally sent material containing live smallpox virus instead of cowpox vaccine to a physician in Tarboro, North Carolina. This caused a local smallpox outbreak, infecting around 60 people and resulting in approximately 10 deaths. This error damaged public and Congressional trust in the federal program’s ability to safely handle and distribute vaccine matter.

The great promise of vaccination, which seemed to raise the possibility of the scientific eradication of deadly disease under the guidance of elite healers, had fallen into disrepute.

Even so, when the Civil War broke out in 1861, there was a push to get all soldiers vaccinated to stop deadly smallpox outbreaks. With that came a slew of injuries and deaths. Historian Terry Reimer writes:

“Unfavorable results from vaccination, or spurious vaccinations, were all too common. Even pure vaccine, obtained from official Army dispensaries, sometimes caused complications. Sometimes, faulty preservation of the crusts could have compromised their effectiveness. As is the case even with modern vaccines today, occasionally, the vaccine did not take, failing to produce the major reaction at the vaccination site that was expected. In other cases, the site of the vaccination became overly sore and swollen, and abnormal pustules developed, leaving surgeons to question whether those vaccinations had been effective.

“Complications from using a scab from a recently vaccinated adult were even more deleterious. Since many vaccinations took place in hospitals, crusts from men who were sick with other conditions were occasionally used unintentionally, spreading disease rather than preventing it. Often, soldiers in a hospital or prison didn’t get vaccinated until smallpox had already appeared in the facility, increasing the risks for some who might not have otherwise been exposed to the disease.

“Perhaps the worst, and unfortunately common, form of spurious vaccination was the use of scabs that were syphilitic in nature. This occurred both in the hospitals and among the soldiers who self-vaccinated. Misdiagnosing a scab or harvesting crusts from the arm of a soldier who had syphilis would spread this disease to everyone vaccinated from that source. In one notable case, two brigades were affected by a vaccination infection that was thought to be syphilitic in nature. The men were so sick that the brigades were unfit for military service. The epidemic was traced to a single soldier who had obtained vaccination material from a woman who likely had syphilis.

“The Confederate Medical Department attempted to prohibit soldier-to-soldier vaccination to limit these damaging effects. Even civilians were discouraged from self-vaccination, as the consequences of spurious vaccine had spread to the general population as well, leading to a mistrust of the vaccination process.”

At this point in history, we were a century and a half deep into the vaccine experience, and certainly with mixed results owing to unsafe methods and spurious products. But there was no giving up. Quite the contrary. The medical journals of the late 19th century were filled with optimism about the capacity of medical science to cure all diseases and even grant eternal life provided the mixtures and administration were improved.

“There is apparently no inherent reason why man should die,” editorialized American Druggist in 1902, “except our ignorance of the conditions governing the reaction going on in his protoplasm.” This problem can be fixed by “the artificial synthesis of living matter,” with vaccination on the front lines of finding the fix for mortality itself. Yes, there has always been a religious dimension to the ethos of this industry.

The turning point came in 1902 with the Biologics Control Act, the first true intervention by the federal government during the Progressive Era that set the stage for the regulation of all food and medicine. Indeed, this act came four years before Upton Sinclair’s novel The Jungle that inspired the passage of the Federal Meat Inspection Act of 1906.

In popular lore, the meat act was passed by Congress to reign in a dangerous industry and bring strict safety standards to bear in a way that protected public health. But as Murray Rothbard has proven, the real power behind the passage of the act was the meat cartel itself, which not only favored cartelization that crushed smaller competitors but dealt a fatal blow to the traditional practice of farmers slaughtering and processing their own meat. Even to this day, the meatpackers wield all the regulatory power.

Not much has been written about the same efforts undertaken in the vaccine and pharmacology industries four years earlier. But it’s a reasonable assumption that the same forces were at work here too. It took some time, and AI did not help at all, but eventually we found the definitive article on the topic that goes to primary resources to discover precisely what was going on. Sure enough, the Biologics Control Act of 1902 was entirely an industry creation, pushed by the dominant players in the market to crush the competition and passed to shore up public skepticism.



The article in question is “Early Developments in the Regulation of Biologics” by Terry S. Coleman, appearing in Food and Drug Law Journal, 2016. This extraordinary piece demonstrates that the hidden hand behind the law was industry itself. The act was not restraining trade but rather giving it a much-needed credibility boost.

The kickoff for the act was a slew of well-publicized deaths from vaccines in 1901. In Camden, New Jersey, there were 80 infections and 11 deaths from tetanus that were traced to a single poisoned vaccine. In addition, there were other such incidents in Philadelphia, Atlantic City, Cleveland, and Bristol, Pennsylvania.

The reputation of the industry was in free fall. Something had to be done to bolster market share. The industry ran to Washington and pulled out all the stops to get regulated, posing as the business that hated regulation but was willing to acquiesce.

“Histories of the 1902 Act generally describe it simply as a congressional response to the St. Louis and Camden incidents as if the law was the outcome of some routine congressional process.” In actual fact, “the 1902 Act was an initiative of the large biologics manufacturers, and it was enacted with the secret cooperation of Public Health Service.”

“The biologics industry sought passage of the 1902 Act primarily because it feared that the contamination incidents would cause additional state and local health departments to make their own vaccines and antitoxins, wiping out the commercial biologics business….Some medical publications also called for governmental inspection and licensing of biologics manufacturers. The Journal of the American Medical Association editorialized that ‘[i]f necessary, legislation should be had forbidding the sale or use of any antitoxin not. . .tested and certified by some competent authority.’ The New York Times called for more intensive inspection and supervision of commercial biologics producers. In October 1902, the Conference of State and Provincial Boards of Health of North America recommended that vaccine should be produced either by governments or by private producers ‘under the closest supervision of qualified government officials.’”

The leading manufacturer that pushed for the law was Parke-Davis. This is the company that sought to “reduce competition by establishing strict governmental standards that small producers would have difficulty meeting.” Shortly after the law was enacted, Parke-Davis wrote to the Public Health Service with suggestions for regulations stating, “As you are perhaps aware, the regulations cannot be too stringent for us.”⁶

Coleman comments: “It is impossible to disentangle the desire for strict regulations to boost public confidence in biologics from the desire for such regulations to eliminate competitors, but it is noteworthy that several biologics producers went out of business because they were unable to pass PHS inspections.⁶¹

Advisor Bullion Surge

The agency assigned the task of regulating vaccines after 1902 was the Hygienic Laboratory within the Public Health and Marine Hospital Service. In 1930, this became the National Institutes of Health, today headed by Jay Bhattacharya with the mandate to untie the agency’s mission from industry capture.

As for Parke-Davis, it was acquired in 1970 by Warner-Lambert. In 2000, Pfizer acquired Warner-Lambert in a $90 billion merger, the largest in pharmaceutical acquisitions in history at the time. This brought Parke-Davis under Pfizer’s umbrella, where the company remains today.

Then in 1905, the industry received the greatest possible gift from the Supreme Court. In Jacobson v. Massachusetts, the court blessed forced vaccination on grounds that public health must always trump the freedom of conscience. Here we are 123 years later, and the implications of this 1902 act are still being felt, complete with the overwhelming influence of industrial cartels that drive federal regulatory efforts.

The events of 2020-2023 have once again raised profound questions about the power of this industry along with triggering concerns about injury and death from shot mandates. Unlike 1813, 1902, 1905, or 1986, the public today has access to new information sources and best-selling books that detail all the ways in which industry has played fast and loose with science and public health in order to bolster its financial standing.

The industry tried mightily to stop this flow of information using brutal tools of censorship that labelled all vaccine doubt as disinformation, misinformation, and malinformation. These efforts succeeded for a while until First Amendment challenges caused digital companies to relent. The cat is now out of the bag.

In addition, the public lives with the deep wounds and lasting trauma of the Covid period, knowing full well of the industrial interests that pushed for the shocking policies that throttled human rights and wrecked social functioning, all in the interest of pushing an inoculation that not only failed but has caused suffering without precedent. At long last, and after such a long struggle for the freedom to choose, it appears that finally some degree of accountability is coming for an industry that has relied on government backing since its inception.

920x260-1

Donation

Buy author a coffee

Donate

The ONLY faith-driven, patriotic news curator that opposes the left AND the “woke right.”

Listen to "Patriot TV" on Spreaker.






Why Bullion Beats Numismatics and Collectible for Your Safe or IRA

Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.

Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.

Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.

Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.

For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.

Lower Costs and Better Liquidity for Home Storage

When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:

  • You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
  • Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
  • Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
  • Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
  • Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.

In times when quick access to value becomes important, bullion’s simplicity stands out.

Stronger Fit for Precious Metals IRAs

Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.

Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.

Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.

Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.

How to Get Started with Bullion

Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.

Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.

As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.

For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.

Please login to join discussion
  • About
  • Politics
  • Conspiracy
  • Culture
  • Financial
  • Geopolitics
  • Faith
  • Survival
© 2026 Patriot TV.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
    • About
  • Posts

© 2026 Patriot TV.